Encinitas, California
United States
93
2025-06-26
The entities that hold a legal rights for patent applications filed by inventor Mohan Raju:
Raju Mohan from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:
FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#2 | 2025-05-29FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#3 | 2024-07-04ROR-GAMMA MODULATORS
#4 | 2024-01-25FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#5 | 2023-11-02TYK2 PSEUDOKINASE LIGANDS
#6 | 2023-10-26HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#7 | 2023-10-05JAK INHIBITORS
#8 | 2023-09-07ROR-GAMMA MODULATORS
#9 | 2023-07-06LIVER X RECEPTOR (LXR) MODULATORS
#10 | 2023-06-15NLRP3 MODULATORS
#11 | 2023-06-15FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#12 | 2023-01-26JAK INHIBITORS
#13 | 2023-01-05FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#14 | 2022-12-15N-((1,2,3.5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4, 5, 6, 7-TETRAHYDROBENZOFURAN -2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
#15 | 2022-12-08LIVER X RECEPTOR (LXR) MODULATORS
#16 | 2022-08-18NLRP3 MODULATORS
#17 | 2022-07-21HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#18 | 2022-06-09ROR-GAMMA MODULATORS
#19 | 2022-06-02TYK2 pseudokinase ligands
#20 | 2022-05-05TYK2 PSEUDOKINASE LIGANDS
#21 | 2022-04-07BICYCLIC ROR-GAMMA MODULATORS
#22 | 2022-04-07SPIROCYCLIC ROR-GAMMA MODULATORS
#23 | 2022-04-07LIVER X RECEPTOR (LXR) MODULATORS
#24 | 2021-09-23NLRP3 modulators
#25 | 2021-09-02LIVER X RECEPTOR (LXR) MODULATORS
#26 | 2021-07-15FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#27 | 2021-06-03Heterocyclic Compounds for the Treatment of Disease
#28 | 2021-05-20FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#29 | 2021-05-13FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#30 | 2021-05-13Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands
#31 | 2021-04-08LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS
#32 | 2021-03-11ROR-GAMMA MODULATORS
#33 | 2021-02-25Bicyclic RORΞ³ modulators
#34 | 2021-02-25Spirocyclic ROR-gamma modulators
#35 | 2021-02-11Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors
#36 | 2020-12-31FUSED BICYCLIC COMPOUNDS
#37 | 2020-12-24COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS
#38 | 2020-11-26JAK inhibitors
#39 | 2020-10-15FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#40 | 2020-10-15HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#41 | 2020-03-12FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#42 | 2020-03-05Prodrugs for the Treatment of Disease
#43 | 2019-10-10FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
#44 | 2019-09-05Substituted piperazines as ROR-gamma modulators
#45 | 2019-08-08Heterocyclic compounds for the treatment of disease
#46 | 2019-07-11Fused bicyclic compounds for the treatment of disease
#47 | 2019-06-06Liver X receptor (LXR) modulators
#48 | 2018-12-06FUSED BICYCLIC COMPOUNDS
#49 | 2018-05-03Fused bicyclic compounds for the treatment of disease
#50 | 2017-12-14Fused bicyclic compounds for the treatment of disease
#51 | 2017-12-14Fused bicyclic compounds for the treatment of disease
#52 | 2016-10-20LXR modulators
#53 | 2016-10-06LXR modulators
#54 | 2015-10-22LXR MODULATORS
#55 | 2015-02-12Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions
#56 | 2014-06-12LXR MODULATORS
#57 | 2014-02-06Imidazole based LXR modulators
#58 | 2013-11-14TGR5 agonists
#59 | 2012-03-22LXR modulators
#60 | 2012-02-16Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity
#61 | 2011-12-08Pyrrole derivatives as pharmaceutical agents
#62 | 2011-10-27Atropisomers of (hydroxyalkyl) pyrrole derivatives
#63 | 2011-10-271-phenylpyrrole derivatives
#64 | 2011-08-16Modulators of LXR
#65 | 2011-06-16Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands
#66 | 2010-12-30Modulators of LXR
#67 | 2010-07-08Azepinoindole derivatives as pharmaceutical agents
#68 | 2010-04-2911 Ξ²-HSD1 modulators
#69 | 2010-03-25Imidazole based LXR modulators
#70 | 2010-03-18LXR and FXR modulators
#71 | 2010-03-04Modulators of LXR
#72 | 2009-10-0111 Beta-HSD1 Modulators
#73 | 2009-08-13Azepinoindole Derivatives As Pharmaceutical Agents
#74 | 2009-08-06Benzylthiazolone inhibitors of estrogen-related receptors (ERR)
#75 | 2009-04-09Plasma carboxypeptidase B inhibitors
#76 | 2008-09-25Pyrrole derivatives as pharmaceutical agents
#77 | 2008-06-05Isoquinolinone Derivatives and Their Use As Therapeutic Agents
#78 | 2008-05-22Modulators Of Nuclear Receptors
#79 | 2007-12-20Substituted pyrimidine compositions and methods of use
#80 | 2007-09-27Bridged ring structures as pharmaceutical agents
#81 | 2007-09-04Isoquinolinone derivatives and their use as therapeutic agents
#82 | 2006-11-02Plasma carboxypeptidase B inhibitors
#83 | 2006-06-29Imidazolidinedione analogs useful as anticoagulants and antithrombotics
#84 | 2006-06-22Platelet adenosine diphosphate receptor antagonists
#85 | 2006-06-08Platelet adenosine diphosphate receptor antagonists
#86 | 2006-06-06Platelet adenosine diphosphate receptor antagonists
#87 | 2006-05-30Imidazolidinedione analogs useful as anticoagulants and antithrombotics
#88 | 2006-05-04N-heterocyclic derivatives as NOS inhibitors
#89 | 2005-04-14Modulators of LXR
#90 | 2005-03-24Platelet adenosine diphosphate receptor antagonists
#91 | 2005-03-10Azepinoindole derivatives as pharmaceutical agents
#92 | 2005-03-01Platelet adenosine diphosphate receptor antagonists
#93 | 2005-02-17Platelet adenosine diphosphate receptor antagonists
530056 β